Dermatomyositis Interstitial Lung Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-02-28
Clinical Trial Update: Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD) [Phase 3]
Phase 3 trial investigating pirfenidone for efficacy and safety in dermatomyositis-associated interstitial lung disease is in progress with …